Literature DB >> 33270128

Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns.

Mattia Galli1,2, Giuseppe Princi1, Filippo Crea1,2, Domenico D'Amario1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33270128     DOI： 10.1093/ehjcvp/pvaa137

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


× No keyword cloud information.
  4 in total

1.  Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention.

Authors:  Kah Long Aw; Amanda Koh; Han Lin Lee; Aurimas Kudzinskas; Rodney De Palma
Journal:  Open Heart       Date:  2022-01

2.  Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?

Authors:  Ishwarlal Jialal; Naval Vikram
Journal:  Ther Adv Cardiovasc Dis       Date:  2021 Jan-Dec

Review 3.  Colchicine in ischemic heart disease: the good, the bad and the ugly.

Authors:  Domenico D'Amario; Donato Cappetta; Luigi Cappannoli; Giuseppe Princi; Stefano Migliaro; Giovanni Diana; Karim Chouchane; Josip A Borovac; Attilio Restivo; Alessandra Arcudi; Antonella De Angelis; Rocco Vergallo; Rocco A Montone; Mattia Galli; Giovanna Liuzzo; Filippo Crea
Journal:  Clin Res Cardiol       Date:  2021-03-13       Impact factor: 5.460

4.  Coronary artery disease: 'gout' in the artery?

Authors:  Timo E Strandberg; Petri T Kovanen
Journal:  Eur Heart J       Date:  2021-07-21       Impact factor: 29.983
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.